For example, while variants in genes such as PNPLA3 and TM6SF2 strongly predispose to MASLD, they may even protect against hyperlipidemia and cardiovascular disease, as noted above. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.